Literature DB >> 22224762

Induced CD4+Foxp3+ regulatory T cells in immune tolerance.

Angelina M Bilate1, Juan J Lafaille.   

Abstract

Regulatory T lymphocytes are essential to maintain homeostasis of the immune system, limiting the magnitude of effector responses and allowing the establishment of immunological tolerance. Two main types of regulatory T cells have been identified--natural and induced (or adaptive)-and both play significant roles in tuning down effector immune responses. Adaptive CD4(+)Foxp3(+) regulatory T (iTreg) cells develop outside the thymus under a variety of conditions. These include not only antigen presentation under subimmunogenic or noninflammatory conditions, but also chronic inflammation and infections. We speculate that the different origin of iTreg cells (noninflammatory versus inflammatory) results in distinct properties, including their stability. iTreg cells are also generated during homeostasis of the gut and in cancer, although some cancers also favor expansion of natural regulatory T (nTreg) cells. Here we review how iTreg cells develop and how they participate in immunological tolerance, contrasting, when possible, iTreg cells with nTreg cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22224762     DOI: 10.1146/annurev-immunol-020711-075043

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  247 in total

1.  Maternal-fetal immune tolerance, block by block.

Authors:  Michael Gobert; Juan J Lafaille
Journal:  Cell       Date:  2012-07-06       Impact factor: 41.582

2.  MUCOSAL IMMUNOLOGY. Individual intestinal symbionts induce a distinct population of RORγ⁺ regulatory T cells.

Authors:  Esen Sefik; Naama Geva-Zatorsky; Sungwhan Oh; Liza Konnikova; David Zemmour; Abigail Manson McGuire; Dalia Burzyn; Adriana Ortiz-Lopez; Mercedes Lobera; Jianfei Yang; Shomir Ghosh; Ashlee Earl; Scott B Snapper; Ray Jupp; Dennis Kasper; Diane Mathis; Christophe Benoist
Journal:  Science       Date:  2015-08-13       Impact factor: 47.728

3.  Lung CD103+ dendritic cells restrain allergic airway inflammation through IL-12 production.

Authors:  Laura Conejero; Sofía C Khouili; Sarai Martínez-Cano; Helena M Izquierdo; Paola Brandi; David Sancho
Journal:  JCI Insight       Date:  2017-05-18

4.  Restoration of intrahepatic regulatory T cells through MMP-9/13-dependent activation of TGF-β is critical for immune homeostasis following acute liver injury.

Authors:  Ling Lu; Min Feng; Jia Gu; Zanxian Xia; Hongjun Zhang; Sujun Zheng; Zhongping Duan; Richard Hu; Julie Wang; Wei Shi; Cheng Ji; Yi Shen; Guihua Chen; Song Guo Zheng; Yuan-Ping Han
Journal:  J Mol Cell Biol       Date:  2013-12       Impact factor: 6.216

5.  Diacylglycerol kinase ζ limits the generation of natural regulatory T cells.

Authors:  Amanda M Schmidt; Tao Zou; Rohan P Joshi; Theresa M Leichner; Matthew A Pimentel; Connie L Sommers; Taku Kambayashi
Journal:  Sci Signal       Date:  2013-11-26       Impact factor: 8.192

6.  Regulatory T cell reprogramming toward a Th2-cell-like lineage impairs oral tolerance and promotes food allergy.

Authors:  Magali Noval Rivas; Oliver T Burton; Petra Wise; Louis-Marie Charbonnier; Peter Georgiev; Hans C Oettgen; Rima Rachid; Talal A Chatila
Journal:  Immunity       Date:  2015-03-10       Impact factor: 31.745

Review 7.  Beyond regulatory T cells: the potential role for IL-2 to deplete T-follicular helper cells and treat autoimmune diseases.

Authors:  André Ballesteros-Tato
Journal:  Immunotherapy       Date:  2014       Impact factor: 4.196

Review 8.  Regulatory T cells in nonlymphoid tissues.

Authors:  Dalia Burzyn; Christophe Benoist; Diane Mathis
Journal:  Nat Immunol       Date:  2013-09-18       Impact factor: 25.606

Review 9.  Novel insights into anti-CD40/CD154 immunotherapy in transplant tolerance.

Authors:  David F Pinelli; Mandy L Ford
Journal:  Immunotherapy       Date:  2015       Impact factor: 4.196

Review 10.  Restoring self-tolerance in autoimmune diseases by enhancing regulatory T-cells.

Authors:  Prabhakaran Kumar; Shikha Saini; Saad Khan; Swarali Surendra Lele; Bellur S Prabhakar
Journal:  Cell Immunol       Date:  2018-09-29       Impact factor: 4.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.